Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
Clinuvel Pharmaceuticals stock last closed at $6.52, up 3.82% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Clinuvel Pharmaceuticals stock is currently +9.58% from its 52-week low of $5.95, and -20.49% from its 52-week high of $8.20.
How to Buy Clinuvel Pharmaceuticals Stock
Wondering how to invest in Clinuvel Pharmaceuticals stock? Here's how.
Decide where to buy Clinuvel Pharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Clinuvel Pharmaceuticals stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit money your investment account: Pick your payment method and add your info.
Research Clinuvel Pharmaceuticals stock: The Clinuvel Pharmaceuticals ticker symbol is CUVL. Is Clinuvel Pharmaceuticals stock a good investment? Should you buy shares of CUVL? How do CUVL's underlying business fundamentals look? Do top analysts think Clinuvel Pharmaceuticals is a good buy? Why has CUVL's stock price moved recently? (Hint: Our stock research website can help you evaluate if CUVL is a good stock to buy).
Execute your CUVL trade: Decide if you will purchase CUVL shares at the current market price or use a limit order to buy CUVL shares at a given price.
Watch your CUVL position: Create a watchlist to monitor your new investment in Clinuvel Pharmaceuticals shares.
Step 1: Decide where to buy Clinuvel Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy CUVL shares.
A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal details so you are able to buy CUVL stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Clinuvel Pharmaceuticals stock
Once you have figured out the best place to buy Clinuvel Pharmaceuticals stock, it's absolutely critical to evaluate their stock prior to investing, so you can understand the risk as well as the opportunity.
Clinuvel Pharmaceuticals shares quick numbers
CUVL Price
$6.52
1w %
5.84%
1y %
N/A
5y %
N/A
P/E
14.17x
P/B
N/A
P/S
5.34x
PEG
4.18x
Revenue
$61.12M
Earnings
$23.12M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
N/A
Next Earnings
N/A
Next Dividend
N/A
Clinuvel Pharmaceuticals Due Diligence Score
WallStreetZen was designed to help part-time investors do better fundamental analysis quickly.
CUVL's operating cash flow of $27.30M allows it to safely service it's debt of $332.72k.
CUVL earnings of $33.09M is not sufficient to cover its interest payments.
There are more short-term assets than short-term liabilities on the CUVL balance sheet.
CUVL has a low debt to equity ratio of 0.13.
There are more short-term assets than long-term liabilities on the CUVL balance sheet.
Negative Financial Indicators:
CUVL profit margin has gone down from 40.3% to 37.8% in the past year.
CUVL Technicals
SMA10
6.68
SMA20
6.86
SMA50
N/A
SMA100
N/A
SMA200
N/A
MACD
N/A
MACD Signal
N/A
MACD Histogram
N/A
RSI
39.02
Stochastic %K
17.04
Stochastic %D
12.64
StochRSI %K
40
StochRSI %D
35.55
How is CUVL performing as a company?
Last year, CUVL earnings were $23.12M. In the past two year, CUVL's earnings have gone up by 4.65% per year. This was slower than the Biotechnology industry average of 9.71%.
Last year, CUVL revenue was $61.12M. During the past two year, CUVL's revenue has increased by 7.85% per year. This was slower than the Biotechnology industry average of 23.65%.
No, Clinuvel Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your CUVL trade
You have two main types of orders:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally fine for most investors.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Click the Open Trade button and eToro will execute the order.
If you need additional help with investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Clinuvel Pharmaceuticals share?
As of Sep 4, 2026, it costs $6.52 to buy one share of Clinuvel Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.46 shares of CUVL.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.